Simponi (golimumab)

Audience: Rheumatological healthcare professionals
[Posted 05/27/2009] Centocor Ortho Biotech and FDA reminded healthcare professionals of the risk of serious fungal infections associated with TNF-α blockers, including Simponi…



No related posts.